# Safety of Inhaled Zanamivir in Pregnancy

> **NCT01462487** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** Treatment with zanamivir

## Key facts

- **NCT ID:** NCT01462487
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01462487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01462487, "Safety of Inhaled Zanamivir in Pregnancy". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01462487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*